Benchtop device for automated DNA/RNA isolation

QuickGene-Auto12S/QuickGene-Auto24S are benchtop device for automated DNA/RNA isolation. It can isolate high-yield and high-purity of DNA/RNA due to the patented porous membrane. Specific reagent kits are pre-filled reagent strips. These strips are supplied in a sealed condition with required reagents for isolation in one strip to reduce the contamination risk. Key Features Specification Consumables *Warning [...]

New, Complete NGS Workflow Helps Food Businesses Combat Food Fraud

First end-to-end workflow for multi-species screening and identification BASINGSTOKE, England -- Thermo Fisher Scientific announced the introduction of a new, complete next generation sequencing (NGS) workflow for multi-species screening and identification for food authenticity. This comes after Oxoid Ltd. (a part of Thermo Fisher Scientific) and SGS MOLECULAR, S.A. signed a global co-marketing and distribution agreement that [...]

Merck Paves the Way for its Innovation Hub in Southern China

Merck today signed an agreement with the Guangzhou Development District on innovation development in Southern China. DARMSTADT, GERMANY  Company signed agreement with Guangzhou Development District Darmstadt, Germany / Guangzhou, China, November 12, 2018 – Merck, the vibrant science and technology company, today signed an agreement with the Guangzhou Development District on innovation development in Southern China. Pursuant [...]

CATHY ZHOU BECOMES VICE PRESIDENT OF PUROLITE IN CHINA

Hangzhou, China- Purolite is proud to announce the Promotion of Cathy Zhou to the position of Vice President of Purolite China. In her new role, Cathy is responsible for overseeing the day-to-day management of Purolite and Purosoft, reporting to Alan Joynes, Vice President of the Asia Regions. Cathy has been a Purolite employee in Asia for [...]

Pressure BioSciences Achieves Major Milestone in the Development of its Ultra Shear Technology Program

Company Completes Development of First Working Prototype of UST System and Initiates Program to Develop Proprietary Method to Make Water Soluble Oils for Use in Multiple Markets SOUTH EASTON, MA / ACCESSWIRE / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and [...]

Changes to the Board of Directors at Datacolor AG

At the ordinary General Meeting on December 5, 2018, the Board of Directors of Datacolor AG will propose that Hanno Elbraechter (1980), be elected as a new member of the Board of Directors.   Hanno Elbraechter studied Marketing, Finance and Business Law in European Business Program (EBP) at the Ecole de Management (ESC) de Bordeaux, France [...]

CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology

–CRISPR Therapeutics Gains Additional Rights to MaxCyte’s Cell Engineering Technology to Develop CRISPR/Cas9-Based Cell Therapies in Immuno-Oncology– ZUG, SWITZERLAND, CAMBRIDGE, MASS. and GAITHERSBURG, MD – CRISPR Therapeutics (NASDAQ:CRSP) and MaxCyte today announced the expansion of their existing relationship by entering into a non-exclusive commercial license agreement that will allow CRISPR Therapeutics to deploy MaxCyte’s Flow Electroporation® [...]

Freezer with ultra low energy costs

Top of the class for quality, equipment, and energy efficiency: the new freezer   You could be one of the first people to take possession of a new BINDER ultra freezer (UFV). The freezers are just coming off the production line and have undergone strict quality tests. We really are very proud of our new [...]

Henniker Relocation to Manor Park

We are pleased to announce that we have completed the relocation to new premises at Manor Park in Runcorn. The move effectively triples our manufacturing footprint and includes dedicated laboratory space to support our growing research and development activities. Manor Park is situation close to Sci Tech Daresbury,  a national science and innovation campus, and [...]

InDevR’s VaxArray platform to tackle measles-Rubella vaccines

VaxArray to improve potency testing for MR vaccines with support from Bill & Melinda Gates Foundation BOULDER -- InDevR announced today that it will pursue proof of concept development for new VaxArray potency assays for measles (M) and rubella vaccines sponsored by the Bill & Melinda Gates Foundation. The long-term objective is to create in [...]

Access IBO on Knowledge Center